Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana R Sousa

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Allergy and Clinical Immunology|October 1, 2011
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposisPhilippe Gevaert, Nicholas Van Bruaene, Tom Cattaert, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|May 9, 2021
Prediction equations for estimating body weight in older adultsRita S Guerra, Ana R Sousa-Santos, Ana S Sousa, et al.
Pediatric Pulmonology|November 24, 2020
Discordant use of short-acting β<sub>2</sub> agonists in children and adults with severe, uncontrolled asthma from the U-BIOPRED cohortOlga Gorlanova, Eveline Tischhauser, Ian M Adcock, et al.
International Forum of Allergy & Rhinology|June 22, 2023
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-upMartin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2023
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic TherapyClaus Bachert, Amber U Luong, Philippe Gevaert, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polypsLarry Borish, Noam A Cohen, Geoffrey Chupp, et al.
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 2015
Temporal assessment of airway remodeling in severe asthma using quantitative computed tomographySumit Gupta, Ruth Hartley, Amisha Singapuri, et al.
The Journal of Allergy and Clinical Immunology|March 24, 2016
Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center studyRuth A Hartley, Bethan L Barker, Chris Newby, et al.
The European Respiratory Journal|May 3, 2017
Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodellingRachid Berair, Ruth Hartley, Vijay Mistry, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Allergy and Clinical Immunology|October 1, 2011
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposisPhilippe Gevaert, Nicholas Van Bruaene, Tom Cattaert, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|May 9, 2021
Prediction equations for estimating body weight in older adultsRita S Guerra, Ana R Sousa-Santos, Ana S Sousa, et al.
Pediatric Pulmonology|November 24, 2020
Discordant use of short-acting β<sub>2</sub> agonists in children and adults with severe, uncontrolled asthma from the U-BIOPRED cohortOlga Gorlanova, Eveline Tischhauser, Ian M Adcock, et al.
International Forum of Allergy & Rhinology|June 22, 2023
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-upMartin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2023
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic TherapyClaus Bachert, Amber U Luong, Philippe Gevaert, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polypsLarry Borish, Noam A Cohen, Geoffrey Chupp, et al.
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 2015
Temporal assessment of airway remodeling in severe asthma using quantitative computed tomographySumit Gupta, Ruth Hartley, Amisha Singapuri, et al.
The Journal of Allergy and Clinical Immunology|March 24, 2016
Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center studyRuth A Hartley, Bethan L Barker, Chris Newby, et al.
The European Respiratory Journal|May 3, 2017
Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodellingRachid Berair, Ruth Hartley, Vijay Mistry, et al.
Pageof 8